FK1954, Public domain, via Wikimedia Commons By TM Chen, President, Continental Carbon India Limited Policies we lay down today, pave way for the future of domestic industry. For instance, tariffs imposed on goods and services that enter the country can alter the balance of trade between the international trading partner and the tariff imposing country. […]
press
Sputnik V demonstrates 97.6% efficacy according to analysis of data from 3.8 million vaccinated persons in Russia making it the most efficient COVID-19 vaccine in the world
Moscow, April 19, 2021 – The Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced that the Sputnik V vaccine demonstrated efficacy of 97.6%, based on the analysis of data on the infection rate of […]
Guest post: This World Hemophilia Day, lets pledge to raise awareness on one of the most under diagnosed rare diseases in India
Dr. Sachin Jadhav, Group Head Haematology & BMT Department, HCG Hospital, Bangalore, Dr. Meera. V – DCH, DNB (Paed), DM (Hematology) Victoria Hospital, Bangalore, and Dr. Cecil Ross, Professor & Head Hematology, St. John’s By Medical College Hospital, Bangalore India has the second highest number of Hemophilia cases in the world. Yet more than 80% Indians with […]
Press Release-Sputnik V vaccine authorized in India
Moscow, April 13, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that Drug Controller General of India (DCGI) has approved the use of the Russian Sputnik V vaccine against coronavirus in the country. India has become the 60th country to approve Sputnik V. Sputnik V is one of only three […]
Russia is the most trusted vaccine producer alongside the US with Sputnik V being the most recognizable vaccine a YouGov poll shows
New Delhi, March 24, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), announces the results of a YouGov survey with 9.417 respondents from 9 countries on their vaccine preferences and country of preference in terms of vaccine production. According to the survey, 54% of respondents who selected a country they trust […]
RDIF and Virchow Biotech partner for production of Sputnik V vaccine in India
Moscow, March 22, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Virchow Biotech Private Limited (part of the Virchow Group), one of the leading vaccine and pharmaceutical producers in India, announce the agreement to produce in the country up to 200 million doses per year of Sputnik V, the world’s first […]
Guest post: Time to Help Patients With Kidney Disease Live Well: Experts
When 52-year-old Sumita was first diagnosed with kidney failure, the journey of managing the disease for the next one decade was extremely challenging. With both the kidneys affected, she was on haemodialysis, which meant frequenting the hospital thrice a week, following a specific diet and living with financial constraints. Living in the outskirts of a […]
Guest post – Debunked: 5 Obesity myths to let go of
By Dr Anantharaman, Consultant Endocrinologist, Magna Centres for Obesity Diabetes and Endocrinology, Bangalore According to numerous studies & reports, more than 1.9 billion adults are overweight and 650 million are obese globally. In India, over 135 million people are affected by obesity. Obesity presents many medical and financial challenges for the individual, society and government. The […]
India needs a third vaccine to fast forward the fight against COVID 19, Sputnik V could be an appropriate choice: Experts
New Delhi, March 4, 2021: India is steadily moving forward in its efforts to provide immunisation to its frontline workers with DCGI approved Covishield and Covaxin. On one side India is supplying the COVID-19 vaccines to neighbouring countries including Bhutan, Maldives, Nepal, Myanmar, and Bangladesh, on the other side, the country’s vaccine production and delivery […]
Thalassemia Patients Group call for inclusion of patients in policy making at APPIS 2021
New Delhi, 3rd March 2021 – Thalassemia Patients Advocacy Group (TPAG) stressed the importance of involving patients in the policy making at the ongoing Asia Pacific Patient Innovation Summit (APPIS), a unique collaborative partnership initiated to address the evolving capability needs of patient organizations across Asia Pacific and beyond. Themed “Co-creating patient advocacy of the […]